… shareholder value.” About Connect Biopharma Connect Biopharma is a clinical-stage biopharmaceutical … is currently conducting global clinical studies of … current cash and investments position to support … reference purposes only. Investor Relations Contact: Alex …

… ’ve faced: capital markets remain tight, sector … with regulatory authorities. Investors are increasingly recognizing that … you, our shareholders, to: Support your investment with your … a clinical stage specialty biopharmaceutical company leveraging advanced, …

… Leadership from the International Institute for Management Development … a clinical-stage biopharmaceutical company advancing a … voting or investment decision, Helix’s shareholders and other … in domestic and foreign business, market, financial, political, and …

… with regulatory authorities. Investors are increasingly recognizing that … you, our shareholders, to: Support your investment with your … a clinical stage specialty biopharmaceutical company leveraging advanced, … need for additional financing. New factors emerge …

… better than City forecasts. Investors welcomed the encouraging update … RNA that serve a global market estimated to be … into industrial, clinical and biopharmaceutical markets. Partners include the NHS. … 2028. • Oxford Nanopore shares jump as gene sequencer eyes …

… SRRK), a late-stage biopharmaceutical company focused on developing … its second quarter 2025 financial results and provide … or 646-307-1963 (international) and referencing the conference … to, company disclosures, investor presentations and FAQs, Securities …

… Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission … Eastern Time to discuss financial results and provide a … ) or (848) 280-6350 (international) and ask to be joined … Twitter), LinkedIn and Facebook. Investor and Media Contacts: Caitlin …

… Biogen plans to continue investing in multiple modalities and … of the top five biopharmaceutical employers, Biogen employs … footprint which supplies certain international markets. In Europe, the … of new investments in Biogen’s global manufacturing footprint; …

… 00 p.m. CEST) for investors, financial analysts and the general public … About BioNTech Biopharmaceutical New Technologies (BioNTech) is a global next generation immunotherapy … .com. CONTACTS Investor Relations Douglas Maffei, PhD Investors@biontech.de Media …

… Shared access to regulatory-aligned expertise for global … development timelines. "Investors should note that … validated expertise from its international collaborations, including with … and partners with leading biopharmaceutical innovators across Asia, …